Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4041.72% is 16551% below its 5-year average of -24.27%, around the middle of its 5-year range (-9988.24%–4.75%).
28.80% below its 12-month average of -3137.89%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4584.97%.
OPERATING MARGIN
-4041.72%
OPERATING MARGIN AVG TTM
-3137.89%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-24.27%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-28.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-16551.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Milestone Pharmaceuticals Inc.
Market Cap
$97.30M
Operating Margin
-4041.72%
TTM Avg
-3137.89%
3Y Avg
0.00%
5Y Avg
-24.27%
Market Cap
$96.95M
Operating Margin
-1366.43%
TTM Avg
-2706.78%
3Y Avg
-1353.39%
5Y Avg
-914.67%
Market Cap
$93.01M
Operating Margin
-2.82%
TTM Avg
2.49%
3Y Avg
2.00%
5Y Avg
2.00%
Market Cap
$102.24M
Operating Margin
2.45%
TTM Avg
-2.63%
3Y Avg
-0.94%
5Y Avg
2.21%
Market Cap
$103.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$90.73M
Operating Margin
0.00%
TTM Avg
-10.06%
3Y Avg
-113.57%
5Y Avg
-75.71%
Market Cap
$90.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $97.30M | -4041.72% | -3137.89% | 0.00% | -24.27% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.23M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $96.95M | -1366.43% | -2706.78% | -1353.39% | -914.67% |
| PolyPid Ltd. (PYPD)vs › | $99.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.01M | -2.82% | 2.49% | 2.00% | 2.00% |
| The Joint Corp. (JYNT)vs › | $102.24M | 2.45% | -2.63% | -0.94% | 2.21% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $90.73M | 0.00% | -10.06% | -113.57% | -75.71% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rallybio Corporation (RLYB)vs › | $90.32M | -3270.86% | -6391.41% | -3195.70% | -2130.47% |
Gross Margin
94.6%
Operating Margin
-4041.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -4584.97% |
| 2026-03-31 | -9988.24% |
| 2025-12-31 | -1116.24% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | -1550.20% |
| 2022-12-31 | -393.11% |
| 2022-09-30 | -1002.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 4.75% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
